← BioTransfer GEO Dataset Finder
GEO series

Splicing regulatory dynamics for precision analysis and treatment of heterogenous leukemias

GSE292324 Homo sapiens (human) Single-cell RNA-seq 12 samples Submitted 2025/07/09 Platform GPL20301Platform GPL34382
At a glance

Single-cell RNA-seq · human · 12 samples

What it is
Single-cell RNA-seqGene activity measured in thousands of individual cells, so cell types can be told apart. Read from the summary: GEO's own type field only says 'expression profiling by sequencing', so confirm it in the paper.
Organism
Homo sapiens (human)
Topic
Acute myeloid leukemiaThis series is part of our curated briefing on it.
Samples
12 samples: 5 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
Data you can get
A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Paper
Splicing regulatory dynamics for precision analysis and treatment of heterogeneous leukemiasScience translational medicine · 2025
Summary (written by the submitters)
The role of splicing dysregulation in cancer is underscored by splicing factor mutations, however, its impact in the absence of such rare mutations remains poorly understood. Prompted by the finding that splicing uniquely resolved genetic subtypes of cancer, we developed an unsupervised computational workflow called OncoSplice to comprehensively define tumor molecular landscapes.
Read the full summary ↓
In adult and pediatric Acute Myeloid Leukemia (AML), OncoSplice identified the spectrum of driver genetics from splicing profiles alone, defined over a dozen new molecular subtypes recurrent across AML cohorts and discovered a dominant splicing subtype that partially phenocopies U2AF1-mutant splicing. Although pediatric leukemias lack splicing factor mutations, this U2AF1-like subtype similarly spanned pediatric and adult AML genetics and consistently predicted poor prognosis. Using long-read single-cell RNA-Seq, we confirmed discovered U2AF1-like splicing was shared across cell states, co-opts a healthy circadian gene program, was stable through relapse and induced a leukemia stem cell (LSC) program. Pharmacological inhibition of the OncoSplice implicated U2AF1-like splicing regulator, PRMT5, rescued leukemia mis-splicing and inhibited leukemic cell growth. Finally, genetic deletion of IRAK4, a common target of U2AF1-like and PRMT5 treatment, blocked leukemia development in xenograft models and induced differentiation. This work suggests broad splicing dysregulation, in the absence of select mutations, is a therapeutic target in heterogenous leukemias.
Published in
Splicing regulatory dynamics for precision analysis and treatment of heterogeneous leukemias
Venkatasubramanian M, Schwartz L, Ramachandra N et al. · Science translational medicine 2025 · PMID 40333990 · doi:10.1126/scitranslmed.adr1471
This dataset
Download · which file do I need?

Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.

1 · Just have a look

Processed table

The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.

2 · Re-analyse it

Supplementary files

The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE292324_RAW.tar (it can run to tens of gigabytes).

3 · Start from the raw reads

Raw sequencing reads

The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.

What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.

Also filed as BioProject PRJNA1237905 and SRA study SRP571423. Searching any of these in the dataset finder brings you back here.

Study design
5 conditions, mostly in duplicate
AML12 LR scRNA-Seq technical ×4 MDSL-CTL-Sample ×2 MDSL-PRT543-Sample ×2 AML14 LR scRNA-Seq technical ×2 AML7 LR scRNA-Seq technical ×2

Supports a between-group comparison across 12 samples.

How we read this: 5 replicated groups read from 12 sample titles; they account for 12 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.

Samples in this study
More Acute myeloid leukemia datasets

Search all human RNA-seq datasets in GEO →

Share this dataset

Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.